Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pardoll, D. M. Nat. Rev. Cancer. 12, 252–264 (2012).
Barclay, A. N. & Van den Berg, T. K. Ann. Rev. Immunol. 32, 25–50 (2014).
Cynis, H. et al. J. Mol. Biol. 379, 966–980 (2008).
Becker, A. et al. Biol. Chem. 397, 45–55 (2016).
Chen, Y. L. et al. Biochem. J. 442, 403–412 (2012).
Cynis, H., Scheel, E., Saido, T. C., Schilling, S. & Demuth, H. U. Biochemistry 47, 7405–7413 (2008).
Speedy, H. E. et al. Nat .Genet. 46, 56–60 (2014).
Mawby, W. J., Holmes, C. H., Anstee, D. J., Spring, F. A. & Tanner, M. J. Biochem. J. 304, 525–530 (1994).
Berkovits, B. D. & Mayr, C. Nature 522, 363–367 (2015).
Hatherley, D. et al. Mol. Cell. 31, 266–277 (2008).
Acknowledgements
We thank Dr. Weirui Ma and Yufeng Shi for kindly providing CD47 plasmids, Yingcong Wang and Prof. Jumei Shi for providing cell lines. We also thank the members of the Wang lab for their assistance. This work was supported by the National Natural Science Foundation of China (81625019, 31830053, 31871398, 31801177, 31500735, 31801178, 31800757), the Science Technology Commission of Shanghai Municipality (16JC1404500, 18410722000), the Commission of Health and Family Planning of Shanghai Municipality (2017BR014 to P.W.; 2017YQ068 to L.F.), the Young Elite Scientist Sponsorship Program by CAST(YESS)(2018QNRC001), the Shanghai Sailing Program (18YF1419500, 18YF1419300), and the Fundamental Research Funds For the Central Universities (22120170259, 22120180043, 22120180045, 22120180049).
Author information
Authors and Affiliations
Contributions
Z.W., L.W., T.Z., and P.W. conceived the project and designed experiments. Z.W., L.W., T.Z., H.T., L.F., H.T., W.Z., J.G., Y.H., Y.L., and H.Z. performed experiments. Z.W., L.W., T.Z., and P.W. analysis the data. Z.W., L.W., and P.W. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Wu, Z., Weng, L., Zhang, T. et al. Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis. Cell Res 29, 502–505 (2019). https://doi.org/10.1038/s41422-019-0177-0
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41422-019-0177-0
This article is cited by
-
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Signal Transduction and Targeted Therapy (2025)
-
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity
Nature Communications (2025)
-
Novel immunotherapy for gastric cancer: targeting the CD47–SIRPα axis
Cancer and Metastasis Reviews (2025)
-
Emerging phagocytosis checkpoints in cancer immunotherapy
Signal Transduction and Targeted Therapy (2023)
-
Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy
Signal Transduction and Targeted Therapy (2023)
